イスラエルで最高のX線検査医師 - トップ5名の医師

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

専門

• 子供と大人の脚の長さの違いを修正するための四肢延長
• イリザロフ法を用いた四肢の再建手術。骨および軟部組織の欠損を招く外傷後およびその他の状態の治療
• 内部および外部固定具およびその組み合わせを使用した先天性および後天性の四肢変形の治療
• 子供と大人の骨折とその合併症に対する外科的および非外科的治療
• 偽関節、偽結合、骨欠損-骨折の偽関節、偽結合、骨欠損。
• 足首の外傷後関節炎の関節保存治療。
• 股関節の骨切り術
• 脳性麻痺およびその他の神経筋障害に対する整形外科的治療、コンピュータ歩行解析。
• ポンセティ法を用いた先天性の足病およびその他の先天性足変形の治療。
• 教育

ウラジミール・ゴールドマン博士は2002年にエルサレム・ヘブライ大学医学部を卒業しました。卒業後、ホロンのウォルフソン医療センターで一般医療インターンシップを修了しました。その後2009年に、エルサレムのハダッサ医療センターで6年間の整形外科の専門研修を成功裏に修了し、その中で小児整形外科および外傷学分野に特別な関心を示し、大人の外傷学および骨折や怪我の結果の治療にも特に注意を払いました。2009年から2011年まで、ゴールドマン博士は、アメリカ合衆国でリーディングな整形外科病院のニューヨーク特別外科病院で勤務し、小児整形外科の専門知識を高め、さらに変形の矯正および四肢延長の分野の専門研修に1年間を費やしました。専門研修期間終了後、四肢延長および変形矯正の分野での優れた業績により名誉あるバッジを授与されました。

2011年にエルサレムに戻って以来、ゴールドマン博士は小児整形外科の問題および病気の治療、さらに成人と子供の変形矯正および四肢延長に専心しています。

ゴールドマン博士は医学部生および若手医師の教育に積極的に参加しており、臨床的学術研究にも参加しています。

ゴールドマン博士は、イスラエル整形外科学会の後援の下、イスラエル小児整形外科学会のメンバーであり、また北米四肢延長および変形矯正学会のメンバーでもあります。

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.